[Reactive hemophagocytic syndrome in children] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Reactive hemophagocytic syndrome in children]

Arch Pediatr. 2000 Mar;7(3):278-86. Unique Identifier : AIDSLINE MED/20224672
Stephan JL; Galambrun C; Unite d'hematologie et d'oncologie pediatrique, Hopital Nord,; CHRU, Saint-Etienne, France.


Abstract: Reactive haemophagocytic syndrome is characterized by activation and uncontrolled non-malignant proliferation of T lymphocytes and macrophages, leading to a cytokine overproduction, which accounts for the main biological signs. Children usually present with an acute febrile illness, fulminant pancytopenia and hepatosplenomegaly, posing a problem of differential diagnosis with severe sepsis. Hemopoietic cells are actively ingested by monocytes/macrophages in various organs, including lymph nodes, bone marrow, liver and spleen. This exarcerbation of the histiocytic system is currently classified among the reactional histiocytoses. It reflects an inappropriate host immune response. Most patients have a known underlying disease (hemopathy, lupus, systemic juvenile arthritis, HIV infection). In the few cases that occur in the apparent absence of any risk factors, investigations should be made to look for predisposing inherited diseases, such as familial lymphohistiocytosis or Purtilo's disease in boys. The treatment rests on immunosuppressive agents, followed by bone marrow transplantation, which can provide a definitive cure in genetic forms.


Keywords: JOURNAL ARTICLE Arthritis/COMPLICATIONS Bone Marrow Transplantation Child English Abstract Herpesvirus 4, Human/PATHOGENICITY Histiocytosis, Non-Langerhans-Cell/ETIOLOGY/*PATHOLOGY/THERAPY Human Immunosuppressive Agents/*THERAPEUTIC USE Prognosis Risk FactorsKWDjournalarticlearthritis/complicationsbonemarrowtransplantationchildenglishabstractherpesvirus4,human/pathogenicityhistiocytosis,non-langerhans-cell/etiology/KWDpathology/therapyhumanimmunosuppressiveagents/KWDtherapeuticuseprognosisriskfactors
000730
A0071457

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .